
Neoral100 mg
Novartis (Bangladesh) Ltd.
Cyclosporine is used for the following indications, classified by strength of evidence: Established/approved: Prophylaxis of organ rejection in kidney, liver, and heart transplantation and more.
Cyclosporine is used for the following indications, classified by strength of evidence:
Cyclosporine is not indicated for use outside these settings without specialist evaluation.
Dosing of Cyclosporine must be individualized based on indication, formulation, organ function, and blood concentration monitoring. Non-modified and modified (microemulsion) formulations of Cyclosporine are not bioequivalent; any conversion between formulations must be done gradually under close physician supervision with blood level monitoring.
| Indication | Typical Adult Dosing |
|---|---|
| Organ transplant rejection prophylaxis (kidney, liver, heart) | Initial dose commonly 9-15 mg/kg/day (modified formulation, in divided doses) given a few hours before transplantation and continued with corticosteroids, tapering to a maintenance dose (often 3-10 mg/kg/day) guided by trough blood levels, renal function and clinical response. |
| Severe active rheumatoid arthritis (second-line, after inadequate response to methotrexate or other disease-modifying agents) | Initial 2.5 mg/kg/day in two divided doses; may be increased gradually (by up to 0.5-0.75 mg/kg/day) at 8-week intervals to a maximum of about 4 mg/kg/day, based on efficacy and tolerability; often combined with methotrexate. |
| Severe plaque psoriasis (second-line, in immunocompetent patients who have failed at least one systemic therapy) | Initial 2.5 mg/kg/day in two divided doses; may be increased after 4 weeks by up to 0.5 mg/kg/day if response is insufficient, to a maximum of 4 mg/kg/day; treatment courses are generally kept as short as possible. |
| Chronic dry eye disease (ophthalmic emulsion) | One drop in each affected eye twice daily, approximately 12 hours apart. |
Regular monitoring of blood pressure, serum creatinine, and (for oral/systemic use) Cyclosporine trough blood concentrations is required throughout treatment to guide dose adjustments and reduce toxicity risk.
Common side effects of systemic Cyclosporine include:
Less common but serious effects include liver dysfunction, electrolyte disturbances (e.g., high potassium, low magnesium), and - with long-term use - increased risk of malignancies such as lymphoma and skin cancer (see Precautions and Warnings).
With the ophthalmic emulsion, the most common effects are burning or stinging at the site of instillation, eye redness, discharge, watering, eye pain, and blurred vision, which are usually mild and localized.
Cyclosporine is contraindicated in:
For the ophthalmic emulsion, Cyclosporine is contraindicated in patients with active or suspected ocular or periocular infection.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.